Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
Clinical trial NCT03170141 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03170141
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2027-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.